Barely Significant
← all excerpts

Cardioprotective strategies in myocardial ischemia-reperfusion injury: Implications for improving clinical translation.

J Mol Cell Cardiol Plus · 2025 · PMC11967023 · PMID 40182153

Europe PMCDOI
1
hedged sentence
0.1220
closest p · 2.4× alpha
0.1220
boldest claim

The sentences

showed a trendP = 0.122not close (p > 0.1)
The 20- and 80-mg dose groups did not demonstrate a significant difference in all-cause mortality or MI incidence from the placebo group at 36 days, whereas the 120 mg dose group showed a trend toward a 10 % risk reduction ( P = 0.122) [ 163 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.